| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/20/2011 | US8022037 Skin wound healing compositions and methods of use thereof |
| 09/20/2011 | US8022036 Use of thymosin alpha 1 for the treatment of immunological diseases |
| 09/20/2011 | US8022035 Y4 selective receptor agonists for therapeutic interventions |
| 09/20/2011 | US8022033 Echinocandin/carbohydrate complexes |
| 09/20/2011 | US8022032 Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
| 09/20/2011 | US8022031 Liquid composition of factor VII polypeptides |
| 09/20/2011 | US8021879 Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 09/20/2011 | US8021862 Process for preparing human G-CSF |
| 09/20/2011 | US8021861 Pathogenic Escherichia coli associated protein |
| 09/20/2011 | US8021856 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021833 Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions |
| 09/20/2011 | US8021832 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021692 Graft materials containing bioactive substances, and methods for their manufacture |
| 09/20/2011 | US8021684 Haemostatic composition comprising hyaluronic acid |
| 09/20/2011 | US8021664 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 09/20/2011 | US8021660 Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 09/20/2011 | US8021659 Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2615393C Methods and compositions for emergency contraception using endothelin receptor antagonists |
| 09/20/2011 | CA2530611C Biologically active peptide comprising tyrosyl-seryl-valine (ysv) |
| 09/20/2011 | CA2515484C Modulation of insulin like growth factor i receptor expression |
| 09/20/2011 | CA2506068C Pharmaceutical composition containing sfcyr iib or sfcyr iii |
| 09/20/2011 | CA2504377C Pharmaceutical preparation of recombinant factor viii lyophilized without albumin as a stabilizer |
| 09/20/2011 | CA2474035C Macrocyclic peptides active against the hepatitis c virus |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2439415C Cathepsin cysteine protease inhibitors |
| 09/20/2011 | CA2410654C Method and device for concentrating and stabilizing conjugated estrogens from mares' urine |
| 09/20/2011 | CA2400562C Hybrid expression of neisserial proteins |
| 09/20/2011 | CA2395814C Glp-2 formulations comprising phosphate buffer, l-histidine and mannitol or sucrose |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2374043C A somatotropin composition with improved syringeability |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2356009C Vascular endothelial growth factor-x |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/20/2011 | CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| 09/20/2011 | CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer |
| 09/20/2011 | CA2259144C Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 09/20/2011 | CA2225796C Novel formulation for peptide release |
| 09/20/2011 | CA2217522C Isolated frpb nucleic acid molecule and vaccine |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011113048A2 Modulation of cytokine signaling |
| 09/15/2011 | WO2011113036A2 Compositions and methods for expanding bfu-e cells |
| 09/15/2011 | WO2011113013A2 Methods and compositions for treating viral or virally-induced conditions |
| 09/15/2011 | WO2011113005A2 Compositions and methods for combinations of oligoamines with 2-difluoromethylornithine (dfmo) |
| 09/15/2011 | WO2011112983A2 Psrp is a protective antigen against pneumococcal infection |
| 09/15/2011 | WO2011112873A2 Extracorporeal immunoadsorption treatment |
| 09/15/2011 | WO2011112859A2 Methods relating to olanzapine pharmacogenetics |
| 09/15/2011 | WO2011112838A2 Composition and method for treatment of vascular hyperpermeability |
| 09/15/2011 | WO2011112791A1 Modulating aquaporins with relaxin |
| 09/15/2011 | WO2011112732A2 Methods of treating vascular inflammatory disorders |
| 09/15/2011 | WO2011112576A1 Microspheres for sustained release of octreotide acetate |
| 09/15/2011 | WO2011112554A1 Novel therapeutic approaches for birt-hogg-dube (bhd) syndrome |
| 09/15/2011 | WO2011112482A2 Polymeric drug delivery conjugates and methods of making and using thereof |
| 09/15/2011 | WO2011112441A1 Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials |
| 09/15/2011 | WO2011112229A2 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 09/15/2011 | WO2011112101A1 Peptide material, feed composition and preparations and uses thereof |
| 09/15/2011 | WO2011112100A1 Peptide material, feed composition and preparations and uses thereof |
| 09/15/2011 | WO2011112099A1 Peptide material, and preparations and uses thereof |
| 09/15/2011 | WO2011111392A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | WO2011110546A2 Pharmaceutical composition comprising an inhibitor of shp-2 and screening method |
| 09/15/2011 | WO2011110367A2 Method of screening for htra protease inhibitors useful for prophylaxis and therapy of a bacterial infection |
| 09/15/2011 | WO2011110359A1 Stat3 activation inhibitors |
| 09/15/2011 | WO2011110087A1 Combined use of ribonuclease and artemisinsin |
| 09/15/2011 | WO2011110049A1 Anti-hiv fusion polypeptide and use thereof |
| 09/15/2011 | WO2011082196A3 Rapid reconstitution for lyophilized-pharmaceutical suspensions |
| 09/15/2011 | WO2011066316A9 Treating neoplasms with neurotoxin |
| 09/15/2011 | WO2011063048A3 Urinary triaosylceramide (gb3) as a marker of cardiac disease |
| 09/15/2011 | WO2011060427A9 Composition and methods for affecting cytokines and nf-kb |
| 09/15/2011 | WO2011057224A3 Zwitterionic polymer bioconjugates and related methods |
| 09/15/2011 | WO2011053789A3 Pharmaceutical composition and methods to enhance cytotoxic t-cell recognition and maintain t-cell memory against a pathogenic disease |
| 09/15/2011 | WO2011050052A3 Protein agent for diabetes treatment and beta cell imaging |
| 09/15/2011 | WO2011029028A3 Targeted delivery using tissue-specific peptidomimetic ligands |
| 09/15/2011 | WO2010065751A3 Formulations of guanylate cyclase c agonists and methods of use |
| 09/15/2011 | WO2009053536A8 Splice variants of gdnf and uses thereof |
| 09/15/2011 | WO2005124563A9 Compounds and kits for treating muscle disorders and methods of use thereof |
| 09/15/2011 | US20110225664 Meganuclease variants cleaving a dna target sequence from a glutamine synthetase gene and uses thereof |
| 09/15/2011 | US20110224723 Cyanoacrylate tissue adhesives |
| 09/15/2011 | US20110224415 Human muty |
| 09/15/2011 | US20110224406 Interleukin-9 receptor mutants |
| 09/15/2011 | US20110224287 Augmented cognitive training |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224154 Peptide derivative and composition for promoting tear secretion comprising the same |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224152 Synthetic arginine substituted peptides and their use |
| 09/15/2011 | US20110224151 Polymeric Micelle Composition for Treatment of Resistant Cancer and Preparation Method of the Same |
| 09/15/2011 | US20110224150 Methods for effecting regression of tumor mass and size in a metastasized tumor |
| 09/15/2011 | US20110224149 Polynucleotides for use in treating and diagnosing cancers |
| 09/15/2011 | US20110224147 Methods and compositions |
| 09/15/2011 | US20110224146 Augmented cognitive training |
| 09/15/2011 | US20110224145 Neuromodulators and Methods of Use |
| 09/15/2011 | US20110224144 Compositions and methods for diagnosing and treating mental disorders |
| 09/15/2011 | US20110224143 Nucleobindin i variant protein compositions and methods of use |
| 09/15/2011 | US20110224142 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 09/15/2011 | US20110224141 Methods and related compositions for the treatment of cancer |
| 09/15/2011 | US20110224140 Human chorionic gonadotropin (hcg) orally or for injection for the treatment of mood disorders and alcoholism |
| 09/15/2011 | US20110224139 Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |